Cocrystal Pharma, Inc. Quarterly Return On Assets in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Cocrystal Pharma, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q2 2024.
  • Cocrystal Pharma, Inc. Return On Assets for the quarter ending June 30, 2024 was -64 %, a 31.5% decline year-over-year.
  • Cocrystal Pharma, Inc. annual Return On Assets for 2023 was -52.1 %, a 28.1% increase from 2022.
  • Cocrystal Pharma, Inc. annual Return On Assets for 2022 was -72.5 %, a 288% decline from 2021.
  • Cocrystal Pharma, Inc. annual Return On Assets for 2021 was -18.7 %, a 7.51% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -64 -15.3 -31.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -52.9 +37.3 +41.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -52.1 +20.4 +28.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -48.9 +11.3 +18.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -48.7 +1.36 +2.72% Apr 1, 2023 Jun 30, 2023
Q1 2023 -90.1 -70.9 -367% Jan 1, 2023 Mar 31, 2023
Q4 2022 -72.5 -53.8 -288% Oct 1, 2022 Dec 31, 2022
Q3 2022 -60.2 -42.9 -249% Jul 1, 2022 Sep 30, 2022
Q2 2022 -50.1 -32.8 -190% Apr 1, 2022 Jun 30, 2022
Q1 2022 -19.3 +1.33 +6.45% Jan 1, 2022 Mar 31, 2022
Q4 2021 -18.7 +1.52 +7.51% Oct 1, 2021 Dec 31, 2021
Q3 2021 -17.3 +118 +87.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -17.2 +102 +85.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 -20.6 +76.1 +78.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -20.2 +55.9 +73.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -136 -74.8 -123% Jul 1, 2020 Sep 30, 2020
Q2 2020 -119 -67 -129% Apr 1, 2020 Jun 30, 2020
Q1 2020 -96.7 -51.7 -115% Jan 1, 2020 Mar 31, 2020
Q4 2019 -76.1 -31.5 -70.6% Oct 1, 2019 Dec 31, 2019
Q3 2019 -60.9 -61 -55623% Jul 1, 2019 Sep 30, 2019
Q2 2019 -52 -52 -148416% Apr 1, 2019 Jun 30, 2019
Q1 2019 -45.1 -44.3 -6197% Jan 1, 2019 Mar 31, 2019
Q4 2018 -44.6 -43.1 -2824% Oct 1, 2018 Dec 31, 2018
Q3 2018 0.11 +58.8 Jul 1, 2018 Sep 30, 2018
Q2 2018 0.04 +48.9 Apr 1, 2018 Jun 30, 2018
Q1 2018 -0.72 +41.9 +98.3% Jan 1, 2018 Mar 31, 2018
Q4 2017 -1.53 +36.3 +96% Oct 1, 2017 Dec 31, 2017
Q3 2017 -58.7 -41 -230% Jul 1, 2017 Sep 30, 2017
Q2 2017 -48.9 -32.6 -199% Apr 1, 2017 Jun 30, 2017
Q1 2017 -42.7 -27.4 -179% Jan 1, 2017 Mar 31, 2017
Q4 2016 -37.9 -18.4 -94.2% Oct 1, 2016 Dec 31, 2016
Q3 2016 -17.8 -9.66 -119% Jul 1, 2016 Sep 30, 2016
Q2 2016 -16.3 -4.64 -39.7% Apr 1, 2016 Jun 30, 2016
Q1 2016 -15.3 -3.49 -29.6% Jan 1, 2016 Mar 31, 2016
Q4 2015 -19.5 -19.4 -14399% Oct 1, 2015 Dec 31, 2015
Q3 2015 -8.12 -19.2 -173% Jul 1, 2015 Sep 30, 2015
Q2 2015 -11.7 -43 -137% Apr 1, 2015 Jun 30, 2015
Q1 2015 -11.8 +34.3 +74.5% Jan 1, 2015 Mar 31, 2015
Q4 2014 -0.13 +63.6 +99.8% Oct 1, 2014 Dec 31, 2014
Q3 2014 11.1 +99.1 Jul 1, 2014 Sep 30, 2014
Q2 2014 31.3 +106 Apr 1, 2014 Jun 30, 2014
Q1 2014 -46.1 +21.8 +32.1% Jan 1, 2014 Mar 31, 2014
Q4 2013 -63.7 +34.1 +34.9% Oct 1, 2013 Dec 31, 2013
Q3 2013 -88 -4.87 -5.86% Jul 1, 2013 Sep 30, 2013
Q2 2013 -74.3 +30.3 +29% Apr 1, 2013 Jun 30, 2013
Q1 2013 -67.9 +29.4 +30.2% Jan 1, 2013 Mar 31, 2013
Q4 2012 -97.8 Oct 1, 2012 Dec 31, 2012
Q3 2012 -83.2 Jul 1, 2012 Sep 30, 2012
Q2 2012 -105 Apr 1, 2012 Jun 30, 2012
Q1 2012 -97.3 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.